 SOUTH SAN FRANCISCO, Calif., May 27, 2021 GLOBE NEWSWIRE -- Vera Therapeutics, Inc. NASDAQ: VERA, a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that management will provide a corporate presentation and participate in one-on-one investor meetings at the Jefferies Virtual Healthcare Conference, which is taking place June 1-4, 2021. 